Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06604884 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 8 to 9
    • Eligibility criteria expanded, about 8 words
  2. Study sites: 7 to 8v14
  3. Study sites: 6 to 7v13
  4. Study sites: 5 to 6v12
  5. Study sites: 4 to 5v11
Show 9 earlier versionsHide 9 earlier versions
  1. Study sites: 3 to 4v10
  2. Study sites: 2 to 3v9
  3. Study sites: 1 to 2v8
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Dec 2025 to Dec 12, 2025
    • Site details revised
    v7
  5. Study sites: 0 to 1v6
  6. Enrollment target: 250 to 118
    • Primary completion date: Dec 2027 to Aug 2029
    • Start date: Sep 2025 to Dec 2025
    • Study completion date: Dec 2031 to Sep 2033
    v5
  7. Start date: Apr 2025 to Sep 2025v4
  8. Start date: Nov 2024 to Apr 2025v3
  9. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the Pipeline™ Vantage Embolization Device with Shield Technology™ Post Approval Study (PAS) ("Pipeline™ Vantage PAS") is to collect safety and effectiveness data in patients undergoing treatment for intracranial aneurysms (IA) using the Pipeline™ Vantage Embolization Device with Shield Technology™ ("Pipeline™ Vantage Device") in a post approval setting.
Trial Details
NCT Number NCT06604884
Lead Sponsor Medtronic Neurovascular Clinical Affairs
Conditions
(from sponsor)		 Intracranial Aneurysm
Related terms Intracranial Aneurysm
Enrollment 118 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov